Birchview Capital’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Birchview Capital’s Portfolio DOVA Stock Details DOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-50,000	Closed	-$1.4M	–	57
2019 Q3	$1.4M	Hold	50,000	–	–	0.93%	9
2019 Q2	$705K	Hold	50,000	–	–	0.43%	25
2019 Q1	$445K	Buy	50,000 +10,000	+25%	+$81.2K	0.28%	32
2018 Q4	$303K	Buy	40,000 +10,000	+33%	+$161K	0.29%	37
2018 Q3	$629K	Buy	+30,000	New	+$714K	0.41%	27

Birchview Capital's DOVA Position: Q4 2019 in Review

Birchview Capital sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 50,000 shares — an estimated $1.4M sold.

Birchview Capital first reported a position in DOVA in Q3 2018 and held it in 5 quarters. The position peaked at $1.4M in Q3 2019. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

Birchview Capital reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Birchview Capital sold 50,000 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $1.4M.
Birchview Capital first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q3 2018 and held it in 5 quarters.
Birchview Capital's Dova Pharmaceuticals, Inc. Common Stock position peaked at $1.4M in Q3 2019.
0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Birchview Capital's 13F filing for Q4 2019, filed 12 Feb 2020.